Virtual Library

Start Your Search

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer

    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    FP10 - Small Cell Lung Cancer/NET

    • Type: Posters (Featured)
    • Track: Small Cell Lung Cancer/NET
    • Presentations: 5
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      FP10.05 - A Prospective Phase II Study of Apatinib Plus Chemotherapy for Pretreated Patients With Advanced Small Cell Lung Cancer

      00:00 - 00:00  |  Presenter: Kewei Ma

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P02 - Diagnostics and Interventional Pulmonology

    • Type: Posters
    • Track: Diagnostics and Interventional Pulmonology
    • Presentations: 25
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P02.25 - Coexistence of Invasive Adenocarcinoma, Minimally Invasive Adenocarcinoma and Atypical Adenomatous Hyperplasia: A Case Report

      00:00 - 00:00  |  Presenter: Kewei Ma

      • Abstract

      Loading...

  • +

    P75 - Immunotherapy (Phase II/III Trials) - Misc. Topics

    • Type: Posters
    • Track: Immunotherapy (Phase II/III Trials)
    • Presentations: 22
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P75.22 - Efficacy of PD-1/PD-L1 Immune Checkpoint Inhibitors for Advanced NSCLC According to PD-L1 Expression: A Meta-Analysis

      00:00 - 00:00  |  Presenter: Kewei Ma

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P79 - Immunotherapy (Phase II/III Trials) - Immunotherapy Plus Chemotherapy

    • Type: Posters
    • Track: Immunotherapy (Phase II/III Trials)
    • Presentations: 9
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P79.09 - Neoadjuvant Combination Sintilimab plus Chemotherapy in Patients with Resectable Stage IIIA Non-Small Cell Lung Cancer.

      00:00 - 00:00  |  Presenter: Kewei Ma

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P84 - Targeted Therapy - Clinically Focused - ALK

    • Type: Posters
    • Track: Targeted Therapy - Clinically Focused
    • Presentations: 23
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P84.23 - The Safety and Toxicities of ALK -TKIs in ALK-Positive NSCLC: A Systematic Review and Pool Analysis

      00:00 - 00:00  |  Presenter: Kewei Ma

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P86 - Targeted Therapy - Clinically Focused - New Target

    • Type: Posters
    • Track: Targeted Therapy - Clinically Focused
    • Presentations: 23
    • Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
    • +

      P86.23 - Clinical Efficacy Analysis of Apatinib as a Second-Or Further-Line Treatment in Patients With Advanced NSCLC

      00:00 - 00:00  |  Presenter: Kewei Ma

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.